Market Analysis and Insights: Global Contraceptive Drugs Devices Market
The global Contraceptive Drugs Devices market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Contraceptive Drugs Devices market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Contraceptive Drugs Devices market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Contraceptive Drugs Devices market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Contraceptive Drugs Devices market.
Global Contraceptive Drugs Devices Scope and Market Size
The research report includes specific segments by region (country),
by company,
by Type and
by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Oral
Vaginal
Injectable Contraceptive Drugs
Male/Female Contraceptive Devices
Segment by Application
Hospitals
Pharmacies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Bayer Healthcare
Merck
Church & Dwight
Warmer Chilcott
Agile Therapeutics
Pfizer
BioSante Pharmaceuticals
Mayer Laboratories
Pantarhei Bioscience
Teva Pharmaceutical Industries
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Contraceptive Drugs Devices product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Contraceptive Drugs Devices, with price, sales, revenue, and global market share of Contraceptive Drugs Devices from 2019 to 2022.
Chapter 3, the Contraceptive Drugs Devices competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Contraceptive Drugs Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Contraceptive Drugs Devices market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Contraceptive Drugs Devices.
Chapter 13, 14, and 15, to describe Contraceptive Drugs Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Contraceptive Drugs Devices Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
TABLE OF CONTENTS
1 Contraceptive Drugs and Devices Market Overview
1.1 Product Overview and Scope of Contraceptive Drugs and Devices
1.2 Contraceptive Drugs and Devices Segment by Type
1.2.1 Global Contraceptive Drugs and Devices Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Oral
1.2.3 Vaginal
1.2.4 Injectable Contraceptive Drugs
1.2.5 Male/Female Contraceptive Devices
1.3 Contraceptive Drugs and Devices Segment by Application
1.3.1 Global Contraceptive Drugs and Devices Sales Comparison by Application: (2023-2030)
1.3.2 Hospitals
1.3.3 Pharmacies
1.3.4 Others
1.4 Global Contraceptive Drugs and Devices Market Size Estimates and Forecasts
1.4.1 Global Contraceptive Drugs and Devices Revenue 2018-2030
1.4.2 Global Contraceptive Drugs and Devices Sales 2018-2030
1.4.3 Contraceptive Drugs and Devices Market Size by Region: 2018 Versus 2022 Versus 2030
2 Contraceptive Drugs and Devices Market Competition by Manufacturers
2.1 Global Contraceptive Drugs and Devices Sales Market Share by Manufacturers (2018-2023)
2.2 Global Contraceptive Drugs and Devices Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Contraceptive Drugs and Devices Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Contraceptive Drugs and Devices Manufacturing Sites, Area Served, Product Type
2.5 Contraceptive Drugs and Devices Market Competitive Situation and Trends
2.5.1 Contraceptive Drugs and Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Contraceptive Drugs and Devices Players Market Share by Revenue
2.5.3 Global Contraceptive Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Contraceptive Drugs and Devices Retrospective Market Scenario by Region
3.1 Global Contraceptive Drugs and Devices Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Contraceptive Drugs and Devices Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Contraceptive Drugs and Devices Market Facts & Figures by Country
3.3.1 North America Contraceptive Drugs and Devices Sales by Country
3.3.2 North America Contraceptive Drugs and Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Contraceptive Drugs and Devices Market Facts & Figures by Country
3.4.1 Europe Contraceptive Drugs and Devices Sales by Country
3.4.2 Europe Contraceptive Drugs and Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Contraceptive Drugs and Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Contraceptive Drugs and Devices Sales by Region
3.5.2 Asia Pacific Contraceptive Drugs and Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Contraceptive Drugs and Devices Market Facts & Figures by Country
3.6.1 Latin America Contraceptive Drugs and Devices Sales by Country
3.6.2 Latin America Contraceptive Drugs and Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Contraceptive Drugs and Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Contraceptive Drugs and Devices Sales by Country
3.7.2 Middle East and Africa Contraceptive Drugs and Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Contraceptive Drugs and Devices Historic Market Analysis by Type
4.1 Global Contraceptive Drugs and Devices Sales Market Share by Type (2018-2023)
4.2 Global Contraceptive Drugs and Devices Revenue Market Share by Type (2018-2023)
4.3 Global Contraceptive Drugs and Devices Price by Type (2018-2023)
5 Global Contraceptive Drugs and Devices Historic Market Analysis by Application
5.1 Global Contraceptive Drugs and Devices Sales Market Share by Application (2018-2023)
5.2 Global Contraceptive Drugs and Devices Revenue Market Share by Application (2018-2023)
5.3 Global Contraceptive Drugs and Devices Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Bayer Healthcare
6.1.1 Bayer Healthcare Corporation Information
6.1.2 Bayer Healthcare Description and Business Overview
6.1.3 Bayer Healthcare Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bayer Healthcare Contraceptive Drugs and Devices Product Portfolio
6.1.5 Bayer Healthcare Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Contraceptive Drugs and Devices Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Church & Dwight
6.3.1 Church & Dwight Corporation Information
6.3.2 Church & Dwight Description and Business Overview
6.3.3 Church & Dwight Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Church & Dwight Contraceptive Drugs and Devices Product Portfolio
6.3.5 Church & Dwight Recent Developments/Updates
6.4 Warmer Chilcott
6.4.1 Warmer Chilcott Corporation Information
6.4.2 Warmer Chilcott Description and Business Overview
6.4.3 Warmer Chilcott Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Warmer Chilcott Contraceptive Drugs and Devices Product Portfolio
6.4.5 Warmer Chilcott Recent Developments/Updates
6.5 Agile Therapeutics
6.5.1 Agile Therapeutics Corporation Information
6.5.2 Agile Therapeutics Description and Business Overview
6.5.3 Agile Therapeutics Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Agile Therapeutics Contraceptive Drugs and Devices Product Portfolio
6.5.5 Agile Therapeutics Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Pfizer Contraceptive Drugs and Devices Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 BioSante Pharmaceuticals
6.6.1 BioSante Pharmaceuticals Corporation Information
6.6.2 BioSante Pharmaceuticals Description and Business Overview
6.6.3 BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BioSante Pharmaceuticals Contraceptive Drugs and Devices Product Portfolio
6.7.5 BioSante Pharmaceuticals Recent Developments/Updates
6.8 Mayer Laboratories
6.8.1 Mayer Laboratories Corporation Information
6.8.2 Mayer Laboratories Description and Business Overview
6.8.3 Mayer Laboratories Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Mayer Laboratories Contraceptive Drugs and Devices Product Portfolio
6.8.5 Mayer Laboratories Recent Developments/Updates
6.9 Pantarhei Bioscience
6.9.1 Pantarhei Bioscience Corporation Information
6.9.2 Pantarhei Bioscience Description and Business Overview
6.9.3 Pantarhei Bioscience Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Pantarhei Bioscience Contraceptive Drugs and Devices Product Portfolio
6.9.5 Pantarhei Bioscience Recent Developments/Updates
6.10 Teva Pharmaceutical Industries
6.10.1 Teva Pharmaceutical Industries Corporation Information
6.10.2 Teva Pharmaceutical Industries Description and Business Overview
6.10.3 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product Portfolio
6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
7 Contraceptive Drugs and Devices Manufacturing Cost Analysis
7.1 Contraceptive Drugs and Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Contraceptive Drugs and Devices
7.4 Contraceptive Drugs and Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Contraceptive Drugs and Devices Distributors List
8.3 Contraceptive Drugs and Devices Customers
9 Contraceptive Drugs and Devices Market Dynamics
9.1 Contraceptive Drugs and Devices Industry Trends
9.2 Contraceptive Drugs and Devices Market Drivers
9.3 Contraceptive Drugs and Devices Market Challenges
9.4 Contraceptive Drugs and Devices Market Restraints
10 Global Market Forecast
10.1 Contraceptive Drugs and Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Contraceptive Drugs and Devices by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Contraceptive Drugs and Devices by Type (2023-2030)
10.2 Contraceptive Drugs and Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Contraceptive Drugs and Devices by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Contraceptive Drugs and Devices by Application (2023-2030)
10.3 Contraceptive Drugs and Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Contraceptive Drugs and Devices by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Contraceptive Drugs and Devices by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Contraceptive Drugs and Devices Sales Growth Rate Comparison by Type (2023-2030) & (K Units) & (US$ Million)
Table 2. Global Contraceptive Drugs and Devices Sales Growth Rate Comparison by Application (2023-2030) & (K Units) & (US$ Million)
Table 3. Global Contraceptive Drugs and Devices Market Size by Region (US$ Million) (2018 VS 2022 VS 2030)
Table 4. Global Contraceptive Drugs and Devices Market Competitive Situation by Manufacturers in 2022
Table 5. Global Contraceptive Drugs and Devices Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global Contraceptive Drugs and Devices Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Contraceptive Drugs and Devices Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global Contraceptive Drugs and Devices Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market Contraceptive Drugs and Devices Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers Contraceptive Drugs and Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Contraceptive Drugs and Devices Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Contraceptive Drugs and Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Contraceptive Drugs and Devices as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Contraceptive Drugs and Devices Sales by Region (2018-2023) & (K Units)
Table 16. Global Contraceptive Drugs and Devices Sales Market Share by Region (2018-2023)
Table 17. Global Contraceptive Drugs and Devices Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2018-2023)
Table 19. North America Contraceptive Drugs and Devices Sales by Country (2018-2023) & (K Units)
Table 20. North America Contraceptive Drugs and Devices Sales Market Share by Country (2018-2023)
Table 21. North America Contraceptive Drugs and Devices Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America Contraceptive Drugs and Devices Revenue Market Share by Country (2018-2023)
Table 23. Europe Contraceptive Drugs and Devices Sales by Country (2018-2023) & (K Units)
Table 24. Europe Contraceptive Drugs and Devices Sales Market Share by Country (2018-2023)
Table 25. Europe Contraceptive Drugs and Devices Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe Contraceptive Drugs and Devices Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific Contraceptive Drugs and Devices Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific Contraceptive Drugs and Devices Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific Contraceptive Drugs and Devices Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific Contraceptive Drugs and Devices Revenue Market Share by Region (2018-2023)
Table 31. Latin America Contraceptive Drugs and Devices Sales by Country (2018-2023) & (K Units)
Table 32. Latin America Contraceptive Drugs and Devices Sales Market Share by Country (2018-2023)
Table 33. Latin America Contraceptive Drugs and Devices Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America Contraceptive Drugs and Devices Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa Contraceptive Drugs and Devices Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa Contraceptive Drugs and Devices Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa Contraceptive Drugs and Devices Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa Contraceptive Drugs and Devices Revenue Market Share by Country (2018-2023)
Table 39. Global Contraceptive Drugs and Devices Sales by Type (2018-2023) & (K Units)
Table 40. Global Contraceptive Drugs and Devices Sales Market Share by Type (2018-2023)
Table 41. Global Contraceptive Drugs and Devices Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Contraceptive Drugs and Devices Revenue Share by Type (2018-2023)
Table 43. Global Contraceptive Drugs and Devices Price by Type (2018-2023) & (USD/Unit)
Table 44. Global Contraceptive Drugs and Devices Sales (K Units) by Application (2018-2023)
Table 45. Global Contraceptive Drugs and Devices Sales Market Share by Application (2018-2023)
Table 46. Global Contraceptive Drugs and Devices Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Contraceptive Drugs and Devices Revenue Share by Application (2018-2023)
Table 48. Global Contraceptive Drugs and Devices Price by Application (2018-2023) & (USD/Unit)
Table 49. Bayer Healthcare Corporation Information
Table 50. Bayer Healthcare Description and Business Overview
Table 51. Bayer Healthcare Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. Bayer Healthcare Contraceptive Drugs and Devices Product
Table 53. Bayer Healthcare Recent Developments/Updates
Table 54. Merck Corporation Information
Table 55. Merck Description and Business Overview
Table 56. Merck Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. Merck Contraceptive Drugs and Devices Product
Table 58. Merck Recent Developments/Updates
Table 59. Church & Dwight Corporation Information
Table 60. Church & Dwight Description and Business Overview
Table 61. Church & Dwight Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Church & Dwight Contraceptive Drugs and Devices Product
Table 63. Church & Dwight Recent Developments/Updates
Table 64. Warmer Chilcott Corporation Information
Table 65. Warmer Chilcott Description and Business Overview
Table 66. Warmer Chilcott Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. Warmer Chilcott Contraceptive Drugs and Devices Product
Table 68. Warmer Chilcott Recent Developments/Updates
Table 69. Agile Therapeutics Corporation Information
Table 70. Agile Therapeutics Description and Business Overview
Table 71. Agile Therapeutics Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. Agile Therapeutics Contraceptive Drugs and Devices Product
Table 73. Agile Therapeutics Recent Developments/Updates
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Business Overview
Table 76. Pfizer Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Pfizer Contraceptive Drugs and Devices Product
Table 78. Pfizer Recent Developments/Updates
Table 79. BioSante Pharmaceuticals Corporation Information
Table 80. BioSante Pharmaceuticals Description and Business Overview
Table 81. BioSante Pharmaceuticals Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. BioSante Pharmaceuticals Contraceptive Drugs and Devices Product
Table 83. BioSante Pharmaceuticals Recent Developments/Updates
Table 84. Mayer Laboratories Corporation Information
Table 85. Mayer Laboratories Description and Business Overview
Table 86. Mayer Laboratories Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Mayer Laboratories Contraceptive Drugs and Devices Product
Table 88. Mayer Laboratories Recent Developments/Updates
Table 89. Pantarhei Bioscience Corporation Information
Table 90. Pantarhei Bioscience Description and Business Overview
Table 91. Pantarhei Bioscience Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Pantarhei Bioscience Contraceptive Drugs and Devices Product
Table 93. Pantarhei Bioscience Recent Developments/Updates
Table 94. Teva Pharmaceutical Industries Corporation Information
Table 95. Teva Pharmaceutical Industries Description and Business Overview
Table 96. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Teva Pharmaceutical Industries Contraceptive Drugs and Devices Product
Table 98. Teva Pharmaceutical Industries Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Contraceptive Drugs and Devices Distributors List
Table 102. Contraceptive Drugs and Devices Customers List
Table 103. Contraceptive Drugs and Devices Market Trends
Table 104. Contraceptive Drugs and Devices Market Drivers
Table 105. Contraceptive Drugs and Devices Market Challenges
Table 106. Contraceptive Drugs and Devices Market Restraints
Table 107. Global Contraceptive Drugs and Devices Sales Forecast by Type (2023-2030) & (K Units)
Table 108. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Type (2023-2030)
Table 109. Global Contraceptive Drugs and Devices Revenue Forecast by Type (2023-2030) & (US$ Million)
Table 110. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Type (2023-2030)
Table 111. Global Contraceptive Drugs and Devices Sales Forecast by Application (2023-2030) & (K Units)
Table 112. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Application (2023-2030)
Table 113. Global Contraceptive Drugs and Devices Revenue Forecast by Application (2023-2030) & (US$ Million)
Table 114. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Application (2023-2030)
Table 115. Global Contraceptive Drugs and Devices Sales Forecast by Region (2023-2030) & (K Units)
Table 116. Global Contraceptive Drugs and Devices Sales Market Share Forecast by Region (2023-2030)
Table 117. Global Contraceptive Drugs and Devices Revenue Forecast by Region (2023-2030) & (US$ Million)
Table 118. Global Contraceptive Drugs and Devices Revenue Market Share Forecast by Region (2023-2030)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Contraceptive Drugs and Devices
Figure 2. Global Contraceptive Drugs and Devices Market Share by Type in 2022 & 2030
Figure 3. Oral Product Picture
Figure 4. Vaginal Product Picture
Figure 5. Injectable Contraceptive Drugs Product Picture
Figure 6. Male/Female Contraceptive Devices Product Picture
Figure 7. Global Contraceptive Drugs and Devices Market Share by Application in 2022 & 2030
Figure 8. Hospitals
Figure 9. Pharmacies
Figure 10. Others
Figure 11. Global Contraceptive Drugs and Devices Revenue, (US$ Million), 2018 VS 2022 VS 2030
Figure 12. Global Contraceptive Drugs and Devices Market Size (2018-2030) & (US$ Million)
Figure 13. Global Contraceptive Drugs and Devices Sales (2018-2030) & (K Units)
Figure 14. Contraceptive Drugs and Devices Sales Share by Manufacturers in 2022
Figure 15. Global Contraceptive Drugs and Devices Revenue Share by Manufacturers in 2022
Figure 16. The Global 5 and 10 Largest Contraceptive Drugs and Devices Players: Market Share by Revenue in 2022
Figure 17. Contraceptive Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 18. Global Contraceptive Drugs and Devices Sales Market Share by Region (2018-2023)
Figure 19. Global Contraceptive Drugs and Devices Sales Market Share by Region in 2022
Figure 20. Global Contraceptive Drugs and Devices Revenue Market Share by Region (2018-2023)
Figure 21. Global Contraceptive Drugs and Devices Revenue Market Share by Region in 2022
Figure 22. U.S. Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 23. Canada Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 24. Germany Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 25. France Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 26. U.K. Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. Italy Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. Russia Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. China Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. Japan Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. South Korea Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. India Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. Australia Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. Taiwan Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. Indonesia Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. Thailand Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Malaysia Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Philippines Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Vietnam Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Mexico Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Brazil Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Argentina Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. Turkey Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Saudi Arabia Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 45. U.A.E Contraceptive Drugs and Devices Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 46. Sales Market Share of Contraceptive Drugs and Devices by Type (2018-2023)
Figure 47. Manufacturing Cost Structure of Contraceptive Drugs and Devices
Figure 48. Manufacturing Process Analysis of Contraceptive Drugs and Devices
Figure 49. Contraceptive Drugs and Devices Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
